# Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

> **NCT06783127** · — · RECRUITING · sponsor: **Santa Chiara Hospital** · enrollment: 3000 (estimated)

## Conditions studied

- Prostate Cancer
- Castrate Resistant Prostate Cancer
- BRCA Mutation

## Interventions

- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT06783127
- **Lead sponsor:** Santa Chiara Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06783127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06783127, "Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06783127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*